Join leading researchers from the United States and Israel at the US-Israel Alzheimer's Disease Conference, as they collaborate to find a cure for Alzheimer's and improve disease management. This conference aims to promote collaboration, support young scientists, and exchange ideas in the fight against Alzheimer's.
US-Israel Alzheimer's Disease Conference: Fostering Collaboration in the Pursuit of a Cure
( Credit to: Jpost )
Join leading researchers from the United States and Israel at the US-Israel Alzheimer's Disease Conference, as they collaborate to find a cure for Alzheimer's and improve disease management. This conference aims to promote collaboration, support young scientists, and exchange ideas in the fight against Alzheimer's.
Alzheimer's disease is a global challenge that requires international cooperation. The US-Israel Alzheimer's Disease Conference, organized by esteemed researchers from Rutgers University, Tel Aviv University, and the Hebrew University of Jerusalem, brings together scientists from both countries to accelerate progress in finding a cure and enhancing the lives of those affected by this devastating disease.
Professors Mark Gluck and Michal Schnaider Beeri, along with Professors Illana Gozes and Hermona Soreq, have spearheaded this conference to foster collaboration and cooperation between American and Israeli researchers. By creating a platform for scientists to share their knowledge and exchange ideas, the conference aims to accelerate breakthroughs in Alzheimer's research.
Promoting Collaboration and Support for Young Scientists
The US-Israel Alzheimer's Disease Conference not only aims to promote collaboration among leading researchers but also to support young scientists in their research efforts. Professors Mark Gluck and Michal Schnaider Beeri are raising funds for travel fellowships to enable undergraduate and graduate students from Rutgers University to attend the conference and present their research studies related to aging, brain health, and Alzheimer's disease.
These fellowships not only provide valuable opportunities for young researchers to showcase their work but also foster cultural and global exchange. The organizers hope that by bringing together students and scientists from different backgrounds, new perspectives and ideas can be generated to advance Alzheimer's research.
Additionally, the conference aims to connect Israeli students with opportunities for advanced training in neuroscience and neurology at Rutgers and other U.S. universities. Professors Gluck and Beeri plan to create a job fair specifically for Israeli students, providing them with a chance to explore potential career paths and further their education in the field.
A Platform for Collaboration and Exchange of Ideas
The US-Israel Alzheimer's Disease Conference serves as a platform for scientists to collaborate and exchange ideas in their pursuit of understanding, preventing, and treating Alzheimer's disease. The conference will cover various topics, including molecular, cellular, systems, behavioral, and cognitive neuroscience approaches.
Presentations will include laboratory-based and animal studies, as well as human clinical studies. This diverse range of research will provide attendees with a comprehensive understanding of the latest advancements in Alzheimer's research and potential treatment strategies.
By bringing together scientists, clinicians, and students from both countries, the conference aims to foster collaboration and encourage interdisciplinary research. The exchange of ideas and perspectives will contribute to a more holistic approach to understanding and combating Alzheimer's disease.
Looking Ahead: Brainright Israel and International Collaboration
Professors Mark Gluck and Michal Schnaider Beeri have plans to launch an international educational exchange program called Brainright Israel. This program will offer summer internships for Rutgers students in brain research labs in Israel, providing them with valuable research experience and a deeper understanding of global efforts to combat Alzheimer's disease.
By fostering international collaborations and providing students with unique research opportunities, Brainright Israel aims to further accelerate progress in Alzheimer's research. Through this program, young researchers will have the chance to work alongside leading scientists in Israel, contributing to the global fight against Alzheimer's.
The US-Israel Alzheimer's Disease Conference and Brainright Israel are just two examples of the ongoing efforts to bring together researchers from different countries and disciplines to tackle Alzheimer's disease. By working together, scientists can pool their resources, expertise, and perspectives to drive advancements in understanding and treating this devastating disease.